Starling Oncology (STLNW) Cash from Operations Growth (3y) (2023 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Cash from Operations Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 2.88% |
| 2 | RadNet | 5.50 Bn | 4.77 Bn | 88.08 Mn | 11.40% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -3.03% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | - |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | -47.51% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.75 Bn | - | 12.06% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | -12.79% |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | 4.41% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | 7.81% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 50.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.06% |
| Mar 31, 2026 | 47.66% |
| Dec 31, 2025 | 30.67% |
| Sep 30, 2025 | 14.77% |
| Jun 30, 2025 | 0.57% |
| Mar 31, 2025 | 33.53% |
| Dec 31, 2024 | 29.49% |
| Sep 30, 2024 | 32.11% |
| Jun 30, 2024 | -29.99% |
| Mar 31, 2024 | -230.90% |
| Dec 31, 2023 | -80.27% |
| Sep 30, 2023 | -392.84% |
| Jun 30, 2023 | -178.07% |